Ren Jinsheng is a Chinese businessman, the Founder and Chairman of Simcere Pharmaceutical Group (HKSE: 2096), a major pharmaceutical supplier.

He holds an undergraduate degree in traditional Chinese pharmacology from the Nanjing University of Chinese Medicine and an MBA from Nanjing Normal University. Simcere has R&D centers in Nanjing, Shanghai, and Boston.

• Core Company: Simcere Pharmaceutical Group, a pharmaceuticals supplier.
• Education: Degree in traditional Chinese pharmacology and an MBA.
• R&D Footprint: Maintains research centers in Nanjing, Shanghai, and Boston.

Ren Jinsheng leveraged his background in traditional Chinese pharmacology to establish Simcere Pharmaceutical Group. His structural achievement lies in building a pharmaceuticals supplier with significant R&D capabilities and a commitment to high-quality drug distribution.

His strategy includes maintaining R&D facilities internationally, like the one in Boston, to access global pharmaceutical expertise. His wealth is secured by the company's public listing and market position in the essential healthcare sector.